Scinai Immunotherapeutics (SCNI) Enterprise Value (2015 - 2026)
Scinai Immunotherapeutics (SCNI) posted Enterprise Value of -$3.1 billion for Q1 2026, down 1953.26% sequentially from -$151.7 million in Q4 2025, and down 270918.28% YoY from N/an in Q1 2025.
Scinai Immunotherapeutics (SCNI) Enterprise Value (2015 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Enterprise Value for 12 years, with the latest figure at -$3.1 billion in Q1 2026.
- Quarterly Enterprise Value fell 270918.28% year-over-year to -$3.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.1 billion (down 270918.28% YoY) and the FY2025 annual result came in at -$151.7 million, down 7139.19% from the prior year.
- Enterprise Value retreated to -$3.1 billion in Q1 2026 per SCNI's latest filing, from -$151.7 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$1.1 million in Q1 2025 and troughed at -$3.1 billion in Q1 2026.
- A 5-year average of -$211.4 million and a median of -$10.1 million in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2025 and 2026: Enterprise Value soared 77.69% in 2025, then plunged 270918.28% in 2026.
- Over 5 years, Enterprise Value stood at -$14.2 million in 2022, then surged by 64.76% to -$5.0 million in 2023, then soared by 58.18% to -$2.1 million in 2024, then sank by 7139.19% to -$151.7 million in 2025, then plunged by 1953.26% to -$3.1 billion in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$3.1 billion, -$151.7 million, and -$1.3 million for Q1 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | Scinai Immunotherapeutics | 1.08 Mn | -3.11 Bn | -1.12 Mn | -3.11 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.11 Bn |
| Dec 31, 2025 | -151.66 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Mar 31, 2025 | -1.15 Mn |
| Dec 31, 2024 | -2.10 Mn |
| Sep 30, 2024 | -5.15 Mn |
| Jun 30, 2024 | -3.35 Mn |
| Mar 31, 2024 | -5.15 Mn |
| Dec 31, 2023 | -5.01 Mn |
| Sep 30, 2023 | -14.34 Mn |
| Jun 30, 2023 | -14.34 Mn |
| Mar 31, 2023 | -14.34 Mn |
| Dec 31, 2022 | -14.22 Mn |
| Sep 30, 2022 | -8.58 Mn |
| Jun 30, 2022 | -11.56 Mn |
| Mar 31, 2022 | -15.39 Mn |
| Dec 31, 2021 | -17.52 Mn |
| Sep 30, 2021 | -10.74 Mn |
| Jun 30, 2021 | -48.58 Mn |
| Mar 31, 2021 | -2.83 Mn |